CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
126:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
NEPHROBLASTOMA  :@0.084848:0.096077:0.312013:0.096077:0.312013:0.076481:0.084848:0.076481:0.017404:0.012230:0.013170:0.015993:0.013641:0.019756:0.013641:0.010348:0.017404:0.012230:0.009878:0.019756:0.021167:0.017404:0.006562:0.006585
OR WILMS' TUMOUR:@0.084848:0.115335:0.302630:0.115335:0.302630:0.095738:0.084848:0.095738:0.019756:0.013641:0.006585:0.021167:0.006585:0.010348:0.021167:0.012230:0.005174:0.006585:0.009878:0.015052:0.021167:0.019756:0.015052:0.013641
Nephroblastoma is a paediatric kidney :@0.084848:0.133938:0.481059:0.133938:0.481059:0.118182:0.084848:0.118182:0.014239:0.012508:0.013123:0.011738:0.005705:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.012450:0.003848:0.007466:0.012450:0.013143:0.012450:0.013123:0.013143:0.012508:0.013181:0.003848:0.013143:0.006523:0.005792:0.003848:0.012450:0.012450:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330
tumour  in  children  under  five  years  of :@0.084848:0.150249:0.481084:0.150249:0.481084:0.134493:0.084848:0.134493:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330:0.007760:0.003848:0.011738:0.005330:0.007776:0.012450:0.011738:0.003848:0.003848:0.013181:0.005713:0.012508:0.011738:0.005330:0.007772:0.011699:0.011738:0.013181:0.012508:0.005792:0.005330:0.007764:0.004686:0.004686:0.010660:0.012508:0.005330:0.007772:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.007778:0.012604:0.006042:0.005330
age, usually  present in one kidney, but :@0.084848:0.166561:0.481080:0.166561:0.481080:0.150805:0.084848:0.150805:0.013143:0.012950:0.012508:0.005330:0.010833:0.011699:0.007466:0.011699:0.013143:0.003848:0.003848:0.010314:0.005330:0.005519:0.013123:0.005711:0.012508:0.007466:0.012508:0.011738:0.006523:0.010833:0.003848:0.011738:0.010833:0.012604:0.011738:0.012508:0.010833:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330:0.010833:0.013123:0.011699:0.006523:0.005330
may rarely affect both kidneys  (bilateral :@0.084848:0.182872:0.481057:0.182872:0.481057:0.167116:0.084848:0.167116:0.018049:0.013143:0.010314:0.009140:0.005792:0.013143:0.005711:0.012508:0.003848:0.010314:0.009140:0.013143:0.006100:0.006042:0.012508:0.012450:0.006523:0.009140:0.013123:0.012604:0.006523:0.011738:0.009140:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.007466:0.005330:0.003822:0.007100:0.013123:0.003848:0.003848:0.013143:0.006523:0.012508:0.005792:0.013143:0.003848:0.005330
disease).  Clinically, the children present :@0.084848:0.199184:0.481079:0.199192:0.481079:0.183436:0.084848:0.183428:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007100:0.005330:0.012444:0.008168:0.015644:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.008178:0.006523:0.011738:0.012508:0.008163:0.012450:0.011738:0.003848:0.003848:0.013181:0.005713:0.012508:0.011738:0.008163:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.711980
14:@0.167408:0.193573:0.179838:0.193573:0.179838:0.184387:0.167408:0.184387:0.006215:0.006215
with an asymptomatic abdominal tumour, :@0.084843:0.215504:0.481061:0.215504:0.481061:0.199748:0.084843:0.199748:0.015990:0.003848:0.006523:0.011738:0.005080:0.013143:0.011738:0.005080:0.013143:0.007466:0.010314:0.018049:0.013123:0.006523:0.012604:0.018049:0.013143:0.006523:0.003848:0.012450:0.005080:0.013143:0.013123:0.013181:0.012604:0.018049:0.003848:0.011738:0.013143:0.003848:0.005092:0.006523:0.011699:0.018049:0.012604:0.011699:0.003758:0.005330:0.005330
but may have fever or  pain and loss of :@0.084843:0.231815:0.481108:0.231815:0.481108:0.216059:0.084843:0.216059:0.013123:0.011699:0.006523:0.009275:0.018049:0.013143:0.010314:0.009275:0.011738:0.013143:0.010660:0.012508:0.009275:0.006042:0.012508:0.010660:0.012508:0.005792:0.009275:0.012604:0.005792:0.005330:0.003931:0.013123:0.013143:0.003848:0.011738:0.009275:0.013143:0.011738:0.013181:0.009275:0.003848:0.012604:0.007466:0.007466:0.009275:0.012604:0.006042:0.005330
appetite. These children may also have :@0.084843:0.248127:0.481086:0.248127:0.481086:0.232371:0.084843:0.232371:0.013143:0.013123:0.013123:0.012508:0.006523:0.003848:0.006523:0.012508:0.005330:0.010045:0.008197:0.011738:0.012508:0.007466:0.012508:0.010045:0.012450:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.010045:0.018049:0.013143:0.010314:0.010045:0.013143:0.003848:0.007466:0.012604:0.010045:0.011738:0.013143:0.010660:0.012508:0.005330
hypertension.  The  disease may be  asso-:@0.084843:0.264438:0.475758:0.264438:0.475758:0.248682:0.084843:0.248682:0.011738:0.010314:0.013123:0.012508:0.005792:0.006523:0.012508:0.011738:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.004439:0.008197:0.011738:0.012508:0.005330:0.004449:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.009794:0.018049:0.013143:0.010314:0.009794:0.013123:0.012508:0.005330:0.004453:0.013143:0.007466:0.007466:0.012604:0.006388
ciated with aniridia, Beckwith Wiedeman :@0.084843:0.280750:0.481059:0.280750:0.481059:0.264994:0.084843:0.264994:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.007485:0.015990:0.003848:0.006523:0.011738:0.007485:0.013143:0.011738:0.003848:0.005792:0.003848:0.013181:0.003848:0.013143:0.005330:0.007485:0.011045:0.012508:0.012450:0.009660:0.015990:0.003848:0.006523:0.011738:0.007485:0.018584:0.003848:0.012508:0.013181:0.012508:0.018049:0.013143:0.011738:0.005330
syndrome  and other  congenital genito-:@0.084843:0.297061:0.475768:0.297061:0.475768:0.281305:0.084843:0.281305:0.007466:0.010314:0.011738:0.013181:0.005717:0.012604:0.018049:0.012508:0.005330:0.005723:0.013143:0.011738:0.013181:0.011064:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330:0.005713:0.012450:0.012604:0.011738:0.012950:0.012496:0.011738:0.003848:0.006523:0.013143:0.003848:0.011064:0.012950:0.012508:0.011738:0.003848:0.006523:0.012604:0.006388
urinary anomalies and is associated with :@0.084843:0.313373:0.481083:0.313373:0.481083:0.297617:0.084843:0.297617:0.011699:0.005792:0.003848:0.011738:0.013143:0.005792:0.010314:0.008486:0.013143:0.011738:0.012604:0.018049:0.013143:0.003848:0.003848:0.012508:0.007466:0.008486:0.013143:0.011738:0.013181:0.008486:0.003848:0.007466:0.008486:0.013143:0.007466:0.007466:0.012604:0.012450:0.003848:0.013143:0.006523:0.012508:0.013181:0.008486:0.015990:0.003848:0.006523:0.011738:0.005330
WT1:@0.084843:0.329684:0.122173:0.329684:0.122173:0.313929:0.084843:0.313929:0.018473:0.008197:0.010660
 gene mutations (11p13). :@0.122173:0.329684:0.360086:0.329684:0.360086:0.313929:0.122173:0.313929:0.005330:0.012950:0.012508:0.011738:0.012508:0.005330:0.018049:0.011699:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.007100:0.010660:0.010660:0.013123:0.010660:0.010660:0.007100:0.005330:0.005330
Of note is that nephroblastoma is seem-:@0.103027:0.345996:0.475758:0.345996:0.475758:0.330240:0.103027:0.330240:0.016722:0.006042:0.005638:0.011738:0.012604:0.006523:0.012508:0.005623:0.003848:0.007466:0.005638:0.006523:0.011738:0.013143:0.006523:0.005628:0.011738:0.012508:0.013123:0.011738:0.005707:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.005638:0.003848:0.007466:0.005638:0.007466:0.012508:0.012508:0.018049:0.006388
ingly more common in sub-Saharan Africa :@0.084843:0.362308:0.481079:0.362308:0.481079:0.346552:0.084843:0.346552:0.003848:0.011738:0.012950:0.003848:0.010314:0.005157:0.018049:0.012604:0.005711:0.012508:0.005157:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005157:0.003848:0.011738:0.005157:0.007466:0.011699:0.013123:0.006388:0.009583:0.013143:0.011738:0.013143:0.005792:0.013143:0.011738:0.005157:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330
than neuroblastoma, which differs from :@0.084843:0.378619:0.481098:0.378619:0.481098:0.362863:0.084843:0.362863:0.006523:0.011738:0.013143:0.011738:0.011796:0.011738:0.012508:0.011699:0.005711:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.018049:0.013143:0.005330:0.011796:0.015990:0.011738:0.003848:0.012450:0.011738:0.011796:0.013181:0.003848:0.006104:0.006042:0.012508:0.005792:0.007466:0.011796:0.006042:0.005711:0.012604:0.018049:0.005330
Europe and the USA. This is specifically the :@0.084843:0.394931:0.481088:0.394931:0.481088:0.379175:0.084843:0.379175:0.010314:0.011699:0.005713:0.012604:0.013123:0.012508:0.005521:0.013143:0.011738:0.013181:0.005523:0.006523:0.011738:0.012508:0.005517:0.012604:0.009583:0.014239:0.005330:0.005513:0.008197:0.011738:0.003848:0.007466:0.005524:0.003848:0.007466:0.005530:0.007466:0.013123:0.012508:0.012450:0.003848:0.004686:0.004686:0.012450:0.013143:0.003848:0.003848:0.010314:0.005538:0.006523:0.011738:0.012508:0.005330
case for black children.:@0.084843:0.411242:0.312600:0.411242:0.312600:0.395486:0.084843:0.395486:0.012450:0.013143:0.007466:0.012508:0.008390:0.006042:0.012604:0.005792:0.008390:0.013123:0.003848:0.013143:0.012450:0.009660:0.008390:0.012450:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.005330
2,14:@0.312596:0.405650:0.334348:0.405650:0.334348:0.396464:0.312596:0.396464:0.006215:0.003107:0.006215:0.006215
 Nephroblasto-:@0.334353:0.411269:0.475764:0.411269:0.475764:0.395513:0.334353:0.395513:0.008390:0.014239:0.012508:0.013123:0.011738:0.005713:0.012604:0.013123:0.003848:0.013143:0.007466:0.006523:0.012604:0.006388
ma is classified into low risk, intermediate :@0.084856:0.427580:0.481090:0.427580:0.481090:0.411824:0.084856:0.411824:0.018049:0.013143:0.007528:0.003848:0.007466:0.007533:0.012450:0.003848:0.013143:0.007466:0.007466:0.003848:0.004686:0.004686:0.012508:0.013193:0.007526:0.003848:0.011738:0.006523:0.012604:0.007522:0.003848:0.012604:0.015990:0.007526:0.005792:0.003848:0.007466:0.009660:0.005330:0.007526:0.003848:0.011738:0.006523:0.012508:0.006315:0.018049:0.012508:0.013181:0.003848:0.013143:0.006523:0.012508:0.005330
risk and high risk on the basis of the histol-:@0.084856:0.443892:0.475764:0.443892:0.475764:0.428136:0.084856:0.428136:0.005792:0.003848:0.007466:0.009660:0.006350:0.013143:0.011738:0.013181:0.006340:0.011738:0.003848:0.012950:0.011738:0.006337:0.005792:0.003848:0.007466:0.009660:0.006340:0.012604:0.011738:0.006333:0.006523:0.011738:0.012508:0.006333:0.013123:0.013143:0.007466:0.003848:0.007466:0.006350:0.012604:0.006042:0.006337:0.006523:0.011738:0.012508:0.006333:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.006388
ogy  type.  Staging  is done  according  to :@0.084856:0.460203:0.481102:0.460203:0.481102:0.444447:0.084856:0.444447:0.012604:0.012950:0.010314:0.005330:0.004335:0.006523:0.010314:0.013123:0.012508:0.005330:0.005330:0.004335:0.009583:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.005330:0.004337:0.003848:0.007466:0.009679:0.013181:0.012604:0.011738:0.012508:0.005330:0.004333:0.013143:0.012450:0.012450:0.012604:0.005669:0.013181:0.003848:0.011738:0.012950:0.005330:0.004339:0.006523:0.012604:0.005330
prechemotherapy imaging for metastasis :@0.084856:0.476515:0.481098:0.476515:0.481098:0.460759:0.084856:0.460759:0.013123:0.005715:0.012508:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.007314:0.003848:0.018049:0.013143:0.012950:0.003848:0.011738:0.012950:0.007331:0.006042:0.012604:0.005792:0.007331:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330
and  local  operative  findings  at  tumour :@0.084856:0.492827:0.481115:0.492827:0.481115:0.477071:0.084856:0.477071:0.013143:0.011738:0.013181:0.005330:0.006658:0.003848:0.012604:0.012450:0.013143:0.003848:0.005330:0.006664:0.012604:0.013123:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.006658:0.004686:0.004686:0.011738:0.013181:0.003848:0.011738:0.012950:0.007466:0.005330:0.006654:0.013143:0.006523:0.005330:0.006656:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.005330
excision. Prognosis depends on histology :@0.084856:0.509138:0.481100:0.509138:0.481100:0.493382:0.084856:0.493382:0.012508:0.009236:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.009044:0.011392:0.005709:0.012604:0.012950:0.011728:0.012604:0.007466:0.003848:0.007466:0.009044:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.007466:0.009044:0.012604:0.011738:0.009044:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330
risk, age and response to treatment with :@0.084856:0.525450:0.481107:0.525450:0.481107:0.509694:0.084856:0.509694:0.005792:0.003848:0.007466:0.009660:0.005330:0.008101:0.013143:0.012950:0.012508:0.008101:0.013143:0.011738:0.013181:0.008101:0.005711:0.012508:0.007466:0.013123:0.012604:0.011738:0.007466:0.012508:0.008101:0.006523:0.012604:0.008091:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.008091:0.015990:0.003848:0.006523:0.011738:0.005330
the current survival rate more than 90% for :@0.084856:0.541761:0.481113:0.541761:0.481113:0.526005:0.084856:0.526005:0.006523:0.011738:0.012508:0.005138:0.012450:0.011699:0.005792:0.005705:0.012508:0.011738:0.006523:0.005138:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005153:0.005792:0.013143:0.006523:0.012508:0.005138:0.018049:0.012604:0.005707:0.012508:0.005138:0.006523:0.011738:0.013143:0.011738:0.005138:0.010660:0.010660:0.014913:0.005138:0.006042:0.012604:0.005792:0.005330
favourable histology. Treatment consists :@0.084856:0.558073:0.481094:0.558073:0.481094:0.542317:0.084856:0.542317:0.006042:0.013143:0.010660:0.012604:0.011699:0.005792:0.013143:0.013123:0.003848:0.012508:0.012411:0.011738:0.003848:0.007466:0.006523:0.012604:0.003848:0.012604:0.012950:0.010314:0.005330:0.012411:0.007620:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.012411:0.012450:0.012604:0.011738:0.007466:0.003848:0.007466:0.006523:0.007466:0.005330
of pre-operative onco-chemotherapy to :@0.084856:0.574384:0.481117:0.574384:0.481117:0.558628:0.084856:0.558628:0.012604:0.006042:0.009487:0.013123:0.005715:0.012508:0.006388:0.012604:0.013123:0.012508:0.005792:0.013143:0.006523:0.003848:0.010660:0.012508:0.009487:0.012604:0.011738:0.012450:0.012604:0.006388:0.012450:0.011738:0.012508:0.018032:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.009487:0.006523:0.012604:0.005330
shrink the tumour for easier surgical exci-:@0.084856:0.590696:0.475775:0.590696:0.475775:0.574940:0.084856:0.574940:0.007466:0.011738:0.005792:0.003848:0.011738:0.009660:0.008032:0.006523:0.011738:0.012508:0.008034:0.006523:0.011699:0.018049:0.012594:0.011699:0.005792:0.008030:0.006042:0.012604:0.005792:0.008026:0.012508:0.013143:0.007466:0.003848:0.012508:0.005792:0.008043:0.007466:0.011699:0.005805:0.012950:0.003848:0.012450:0.013143:0.003848:0.008043:0.012508:0.009236:0.012450:0.003848:0.006388
sion. Postsurgical treatment  depends on :@0.084856:0.607007:0.481115:0.607007:0.481115:0.591252:0.084856:0.591252:0.007466:0.003848:0.012604:0.011738:0.005330:0.009871:0.011392:0.012604:0.007466:0.006523:0.007466:0.011699:0.005809:0.012950:0.003848:0.012450:0.013143:0.003848:0.009871:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.004528:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.007466:0.009871:0.012604:0.011738:0.005330
stage at excision  with limited disease re-:@0.084856:0.623319:0.475770:0.623319:0.475770:0.607563:0.084856:0.607563:0.007466:0.006523:0.013143:0.012950:0.012508:0.008390:0.013143:0.006523:0.008390:0.012508:0.009236:0.012450:0.003848:0.007466:0.003848:0.012604:0.011738:0.005330:0.003048:0.015990:0.003848:0.006523:0.011738:0.008390:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.008390:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.008390:0.005711:0.012508:0.006388
ceiving limited  further  chemotherapy, :@0.084856:0.639631:0.481111:0.639631:0.481111:0.623875:0.084856:0.623875:0.012450:0.012508:0.003848:0.010660:0.003848:0.011738:0.012950:0.018415:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.005330:0.013073:0.006042:0.011699:0.005792:0.006523:0.011738:0.012508:0.005792:0.005330:0.013054:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.005330
while advanced disease and metastasis :@0.084856:0.655942:0.481077:0.655942:0.481077:0.640186:0.084856:0.640186:0.015990:0.011738:0.003848:0.003848:0.012508:0.009660:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.009660:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.009660:0.013143:0.011738:0.013181:0.009660:0.018049:0.012508:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330
necessitates intensive chemotherapy and :@0.084856:0.672254:0.481086:0.672254:0.481086:0.656498:0.084856:0.656498:0.011738:0.012508:0.012450:0.012508:0.007466:0.007466:0.003848:0.006523:0.013143:0.006523:0.012508:0.007466:0.005792:0.003848:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.010660:0.012508:0.005792:0.012450:0.011738:0.012508:0.018049:0.012594:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005792:0.013143:0.011738:0.013181:0.005330
radiotherapy to the tumour bed. Lung me-:@0.084856:0.688565:0.475768:0.688565:0.475768:0.672809:0.084856:0.672809:0.005792:0.013143:0.013181:0.003848:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.004432:0.006523:0.012604:0.004430:0.006523:0.011738:0.012508:0.004430:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.004422:0.013123:0.012508:0.013181:0.005330:0.004435:0.008890:0.011699:0.011738:0.012950:0.004428:0.018049:0.012508:0.006388
tastasis can be excised if persistent.:@0.084856:0.704877:0.413959:0.704877:0.413959:0.689121:0.084856:0.689121:0.006523:0.013143:0.007466:0.006523:0.013143:0.007466:0.003848:0.007466:0.005330:0.012450:0.013143:0.011738:0.005330:0.013123:0.012508:0.005330:0.012508:0.009236:0.012450:0.003848:0.007466:0.012508:0.013181:0.005330:0.003848:0.006042:0.005330:0.013123:0.012508:0.005792:0.007466:0.003848:0.007466:0.006523:0.012508:0.011738:0.006523:0.005330
RETINOBLASTOMA:@0.084848:0.738187:0.286167:0.738187:0.286167:0.718591:0.084848:0.718591:0.013641:0.012230:0.009878:0.006585:0.017404:0.019756:0.013641:0.010348:0.017404:0.012230:0.009878:0.019756:0.021167:0.017404
Retinoblastoma  is  a  rare  tumour,  but  the :@0.084848:0.756794:0.481105:0.756794:0.481105:0.741038:0.084848:0.741038:0.011295:0.012123:0.006138:0.003464:0.011353:0.012219:0.012738:0.003464:0.012758:0.007081:0.006138:0.012219:0.017665:0.012758:0.005330:0.005240:0.003464:0.007081:0.005330:0.005242:0.012758:0.005330:0.005242:0.005407:0.012758:0.005328:0.012123:0.005330:0.005242:0.006138:0.011315:0.017665:0.012219:0.011315:0.003383:0.004945:0.005330:0.005242:0.012738:0.011315:0.006138:0.005330:0.005242:0.006138:0.011353:0.012506:0.005330
most common eye tumour in children and :@0.084848:0.773106:0.481126:0.773106:0.481126:0.757350:0.084848:0.757350:0.017665:0.012219:0.007081:0.006138:0.007062:0.012065:0.012219:0.017665:0.017665:0.012219:0.011353:0.007062:0.012123:0.009929:0.012123:0.007062:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.007062:0.003464:0.011353:0.007062:0.012065:0.011353:0.003464:0.003464:0.012796:0.005328:0.012123:0.011353:0.007062:0.012758:0.011353:0.013183:0.005330
usually affects young infants and children :@0.084848:0.789417:0.481063:0.789417:0.481063:0.773661:0.084848:0.773661:0.011315:0.007081:0.011315:0.012758:0.003464:0.003464:0.009929:0.009121:0.012758:0.005713:0.005657:0.012123:0.012065:0.006138:0.007081:0.009121:0.009929:0.012219:0.011315:0.011353:0.012565:0.009121:0.003464:0.011353:0.005657:0.012758:0.011353:0.006138:0.007081:0.009121:0.012758:0.011353:0.012796:0.009121:0.012065:0.011353:0.003464:0.003464:0.012796:0.005328:0.012123:0.011736:0.005330
under the age of five years.  There is an im-:@0.084848:0.805729:0.475754:0.805735:0.475754:0.789979:0.084848:0.789973:0.011315:0.011353:0.012796:0.012123:0.005407:0.005165:0.006138:0.011353:0.012123:0.005165:0.012758:0.012565:0.012123:0.005165:0.012219:0.005657:0.005165:0.004493:0.004493:0.010275:0.012123:0.005163:0.009929:0.012123:0.012758:0.005407:0.007081:0.005330:0.011576:0.005165:0.007812:0.011353:0.012123:0.005326:0.012123:0.005165:0.003464:0.007081:0.005163:0.012758:0.011353:0.005165:0.003464:0.017665:-0.163881
15:@0.332202:0.800116:0.344408:0.800116:0.344408:0.790930:0.332202:0.790930:0.005991:0.006215
pression that the tumour incidence is higher :@0.084858:0.822047:0.481149:0.822047:0.481149:0.806291:0.084858:0.806291:0.012738:0.005328:0.012123:0.007081:0.007081:0.003464:0.012219:0.011353:0.005253:0.006138:0.011353:0.012758:0.006138:0.005253:0.006138:0.011353:0.012123:0.005253:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.005253:0.003464:0.011353:0.012065:0.003464:0.012796:0.012123:0.011353:0.012065:0.012123:0.005253:0.003464:0.007081:0.005253:0.011353:0.003464:0.012565:0.011353:0.012123:0.005788:0.005330
in Central and South America, India and :@0.084858:0.838358:0.481078:0.838358:0.481078:0.822602:0.084858:0.822602:0.003464:0.011353:0.009756:0.015259:0.012123:0.011353:0.006138:0.005407:0.012758:0.003464:0.009756:0.012758:0.011353:0.012796:0.009756:0.009198:0.012219:0.011315:0.006138:0.011353:0.009756:0.013855:0.017665:0.012123:0.005407:0.003464:0.012065:0.012758:0.004945:0.009756:0.003964:0.011353:0.012796:0.003464:0.012758:0.009756:0.012758:0.011353:0.013181:0.005330
sub-Saharan Africa. The majority of tumours :@0.084858:0.854670:0.481138:0.854670:0.481138:0.838914:0.084858:0.838914:0.007081:0.011315:0.012738:0.006004:0.009198:0.012758:0.011353:0.012758:0.005407:0.012758:0.011353:0.005657:0.013855:0.005657:0.005407:0.003464:0.012065:0.012758:0.004945:0.005657:0.007812:0.011353:0.012123:0.005657:0.017665:0.012758:0.003521:0.012219:0.005407:0.003464:0.006138:0.009929:0.005657:0.012219:0.005657:0.005657:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.007468:0.005330
appear sporadically, but a small group is as-:@0.084858:0.870981:0.475765:0.870981:0.475765:0.855225:0.084858:0.855225:0.012758:0.012738:0.012738:0.012123:0.012758:0.005407:0.004426:0.007081:0.012738:0.012219:0.005407:0.012758:0.012796:0.003464:0.012065:0.012758:0.003464:0.003464:0.009929:0.004945:0.004426:0.012738:0.011315:0.006138:0.004426:0.012758:0.004426:0.007081:0.017665:0.012758:0.003464:0.003464:0.004426:0.012565:0.005328:0.012219:0.011315:0.012738:0.004426:0.003464:0.007081:0.004426:0.012758:0.007081:0.006388
sociated with a germline mutation in the :@0.084858:0.887293:0.444721:0.887293:0.444721:0.871537:0.084858:0.871537:0.007081:0.012219:0.012065:0.003464:0.012758:0.006138:0.012123:0.012796:0.003733:0.015606:0.003464:0.006138:0.011353:0.003733:0.012758:0.003733:0.012565:0.012123:0.005938:0.017665:0.003464:0.003464:0.011353:0.012123:0.003733:0.017665:0.011315:0.006138:0.012758:0.006138:0.003464:0.012219:0.011353:0.003733:0.003464:0.011353:0.003733:0.006138:0.011353:0.012123:0.005330
RB1:@0.443124:0.887293:0.475740:0.887293:0.475740:0.871537:0.443124:0.871537:0.011295:0.010660:0.010660
 :@0.475767:0.887293:0.481097:0.887293:0.481097:0.871537:0.475767:0.871537:0.005330
gene, leading to the hereditary, often bilat-:@0.084858:0.903604:0.475823:0.903604:0.475823:0.887848:0.084858:0.887848:0.012565:0.012123:0.011353:0.012123:0.004945:0.005426:0.003464:0.012123:0.012758:0.012796:0.003464:0.011353:0.012565:0.005426:0.006138:0.012219:0.005426:0.006138:0.011353:0.012123:0.005426:0.011353:0.012123:0.005328:0.012123:0.012796:0.003464:0.006138:0.012758:0.005407:0.009929:0.004945:0.005426:0.012219:0.005657:0.006138:0.012123:0.011353:0.005426:0.012738:0.003464:0.003464:0.012758:0.006138:0.006388
eral  disease  in  a  younger  age  group.  The :@0.084858:0.919916:0.481115:0.919916:0.481115:0.904160:0.084858:0.904160:0.012123:0.005407:0.012758:0.003464:0.005330:0.003104:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.005330:0.003104:0.003464:0.011353:0.005330:0.003104:0.012758:0.005330:0.003104:0.009929:0.012219:0.011315:0.011353:0.012565:0.012123:0.005407:0.005330:0.003104:0.012758:0.012565:0.012123:0.005330:0.003104:0.012565:0.005328:0.012219:0.011315:0.012738:0.004945:0.005330:0.003104:0.007812:0.011353:0.012506:0.005330
clinical presentation is usually leucocoria :@0.084858:0.936227:0.481097:0.936227:0.481097:0.920472:0.084858:0.920472:0.012065:0.003464:0.003464:0.011353:0.003464:0.012065:0.012758:0.003464:0.012161:0.012738:0.005328:0.012123:0.007081:0.012123:0.011353:0.006138:0.012758:0.006138:0.003464:0.012219:0.011353:0.012161:0.003464:0.007081:0.012161:0.011315:0.007081:0.011315:0.012758:0.003464:0.003464:0.009929:0.012161:0.003464:0.012123:0.011315:0.012065:0.012219:0.012065:0.012219:0.005407:0.003464:0.013144:0.005330
with  an  absent  red  eye  reflex.  The  child :@0.524258:0.096149:0.920511:0.096149:0.920511:0.080393:0.524258:0.080393:0.015606:0.003464:0.006138:0.011353:0.005330:0.005600:0.012758:0.011353:0.005330:0.005600:0.012758:0.012738:0.007081:0.012123:0.011353:0.006138:0.005330:0.005598:0.005328:0.012123:0.012796:0.005330:0.005600:0.012123:0.009929:0.012123:0.005330:0.005600:0.005328:0.012123:0.004474:0.004474:0.012123:0.008852:0.004945:0.005330:0.005600:0.007812:0.011353:0.012123:0.005330:0.005600:0.012065:0.011353:0.003464:0.003464:0.013181:0.005330
may also present with strabismus. Diagnosis :@0.524258:0.112328:0.920480:0.112328:0.920480:0.096572:0.524258:0.096572:0.017665:0.012758:0.009929:0.006319:0.012758:0.003464:0.007081:0.012219:0.006319:0.012738:0.005328:0.012123:0.007081:0.012123:0.011353:0.006138:0.006319:0.015606:0.003464:0.006138:0.011353:0.006319:0.007081:0.006138:0.005407:0.012758:0.012738:0.003464:0.007081:0.017665:0.011315:0.007081:0.004945:0.006319:0.013932:0.003464:0.012758:0.012565:0.011353:0.012219:0.007081:0.003464:0.007470:0.005330
is made with either RETCAM or examination :@0.524258:0.128508:0.920534:0.128508:0.920534:0.112752:0.524258:0.112752:0.003464:0.007081:0.005378:0.017665:0.012758:0.012796:0.012123:0.005378:0.015606:0.003464:0.006138:0.011353:0.005378:0.012123:0.003464:0.006138:0.011353:0.012123:0.005407:0.005378:0.011295:0.009929:0.007812:0.015259:0.013855:0.017299:0.005388:0.012219:0.005407:0.005388:0.012123:0.008852:0.012758:0.017665:0.003464:0.011353:0.012758:0.006138:0.003464:0.012219:0.011736:0.005330
under anaesthesia. Local disease has an :@0.524258:0.144687:0.920494:0.144687:0.920494:0.128931:0.524258:0.128931:0.011315:0.011353:0.012796:0.012123:0.005407:0.010372:0.012758:0.011353:0.012758:0.012123:0.007081:0.006138:0.011353:0.012123:0.007081:0.003464:0.012758:0.004945:0.010372:0.008505:0.012219:0.012065:0.012758:0.003464:0.010372:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.010372:0.011353:0.012758:0.007081:0.010372:0.012758:0.011734:0.005330
excellent prognosis if diagnosed early and :@0.524258:0.160866:0.920496:0.160866:0.920496:0.145110:0.524258:0.145110:0.012123:0.008852:0.012065:0.012123:0.003464:0.003464:0.012123:0.011353:0.006138:0.007582:0.012738:0.005326:0.012219:0.012565:0.011353:0.012219:0.007081:0.003464:0.007081:0.007582:0.003464:0.005657:0.007582:0.012796:0.003464:0.012758:0.012565:0.011353:0.012219:0.007081:0.012123:0.012796:0.007582:0.012123:0.012758:0.005407:0.003464:0.009929:0.007582:0.012758:0.011353:0.013183:0.005330
is amenable to local therapy with vision-:@0.524258:0.177045:0.915129:0.177045:0.915129:0.161289:0.524258:0.161289:0.003464:0.007081:0.010295:0.012758:0.017665:0.012123:0.011353:0.012758:0.012738:0.003464:0.012123:0.010295:0.006138:0.012219:0.010295:0.003464:0.012219:0.012065:0.012758:0.003464:0.010295:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.010295:0.015606:0.003464:0.006138:0.011353:0.010295:0.010275:0.003464:0.007081:0.003464:0.012219:0.011353:0.006388
saving procedures, while local extension :@0.524258:0.193225:0.920469:0.193225:0.920469:0.177469:0.524258:0.177469:0.007081:0.012758:0.010275:0.003464:0.011353:0.012565:0.012565:0.012738:0.005328:0.012219:0.012065:0.012123:0.012796:0.011315:0.005326:0.012123:0.007081:0.004945:0.012565:0.015606:0.011353:0.003464:0.003464:0.012123:0.012565:0.003464:0.012219:0.012065:0.012758:0.003464:0.012565:0.012123:0.008852:0.006138:0.012123:0.011353:0.007081:0.003464:0.012219:0.011734:0.005330
and metastatic disease necessitate onco-:@0.524258:0.209404:0.915168:0.209404:0.915168:0.193648:0.524258:0.193648:0.012758:0.011353:0.012796:0.008390:0.017665:0.012123:0.006138:0.012758:0.007081:0.006138:0.012758:0.006138:0.003464:0.012065:0.008390:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.008390:0.011353:0.012123:0.012065:0.012123:0.007081:0.007081:0.003464:0.006138:0.012758:0.006138:0.012123:0.008390:0.012219:0.011353:0.012065:0.012219:0.006388
chemotherapy. Diagnosis may be delayed :@0.524258:0.225438:0.920494:0.225438:0.920494:0.209682:0.524258:0.209682:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.004945:0.006146:0.013932:0.003464:0.012758:0.012565:0.011353:0.012219:0.007081:0.003464:0.007081:0.006146:0.017665:0.012758:0.009929:0.006148:0.012738:0.012123:0.006146:0.012796:0.012123:0.003464:0.012758:0.009929:0.012123:0.013183:0.005330
in South Africa, as the warning signs may be :@0.524258:0.241471:0.920501:0.241471:0.920501:0.225715:0.524258:0.225715:0.003464:0.011353:0.004778:0.009198:0.012219:0.011315:0.006138:0.011353:0.004778:0.013855:0.005657:0.005407:0.003464:0.012065:0.012758:0.004945:0.004778:0.012758:0.007081:0.004778:0.006138:0.011353:0.012123:0.004778:0.015606:0.012758:0.005807:0.011353:0.003464:0.011353:0.012565:0.004778:0.007081:0.003464:0.012565:0.011353:0.007081:0.004778:0.017665:0.012758:0.009929:0.004780:0.012738:0.012506:0.005330
missed, resulting in metastatic disease with a :@0.524258:0.257505:0.920438:0.257505:0.920438:0.241749:0.524258:0.241749:0.017665:0.003464:0.007081:0.007081:0.012123:0.012796:0.004945:0.004099:0.005326:0.012123:0.007081:0.011315:0.003464:0.006138:0.003464:0.011353:0.012565:0.004099:0.003464:0.011353:0.004099:0.017665:0.012123:0.006138:0.012758:0.007081:0.006138:0.012758:0.006138:0.003464:0.012065:0.004099:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.004099:0.015606:0.003464:0.006138:0.011353:0.004099:0.013144:0.005330
poor prognosis.:@0.524258:0.273539:0.661166:0.273539:0.661166:0.257783:0.524258:0.257783:0.012738:0.012219:0.012219:0.005407:0.004945:0.012738:0.005328:0.012219:0.012565:0.011353:0.012219:0.007081:0.003464:0.007081:0.005330
16,17:@0.660748:0.267911:0.687818:0.267911:0.687818:0.258725:0.660748:0.258725:0.005991:0.005991:0.002883:0.005991:0.006215
CONCLUSION:@0.524242:0.306238:0.679464:0.306238:0.679464:0.286641:0.524242:0.286641:0.018344:0.019756:0.017404:0.018344:0.010348:0.015052:0.012230:0.006585:0.019756:0.017404
In conclusion, early diagnosis is crucial for :@0.524242:0.324561:0.920481:0.324561:0.920481:0.308805:0.524242:0.308805:0.004349:0.011738:0.006369:0.012450:0.012604:0.011738:0.012450:0.003848:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330:0.006369:0.012508:0.013143:0.005792:0.003848:0.010314:0.006369:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.006369:0.003848:0.007466:0.006369:0.012450:0.005792:0.011699:0.012450:0.003848:0.013143:0.003848:0.006369:0.006042:0.012604:0.005792:0.005330
improved survival  in children with can-:@0.524242:0.341031:0.915165:0.341031:0.915165:0.325275:0.524242:0.325275:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.013181:0.012334:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.005330:0.007016:0.003848:0.011738:0.012334:0.012450:0.011738:0.003848:0.003848:0.013181:0.005713:0.012508:0.011738:0.012334:0.015990:0.003848:0.006523:0.011738:0.012334:0.012450:0.013143:0.011738:0.006388
cer. Other rare cancers are not discussed :@0.524242:0.357502:0.920504:0.357502:0.920504:0.341746:0.524242:0.341746:0.012450:0.012508:0.004376:0.005330:0.006465:0.016722:0.006523:0.011738:0.012508:0.005792:0.006465:0.005792:0.013143:0.005711:0.012508:0.006465:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.006465:0.013143:0.005715:0.012508:0.006465:0.011738:0.012604:0.006523:0.006465:0.013181:0.003848:0.007466:0.012450:0.011699:0.007466:0.007466:0.012508:0.013181:0.005330
in this  brief chapter regarding common :@0.524242:0.373972:0.920487:0.373972:0.920487:0.358216:0.524242:0.358216:0.003848:0.011738:0.010391:0.006523:0.011738:0.003848:0.007466:0.005330:0.005072:0.013123:0.005792:0.003848:0.012508:0.006042:0.010391:0.012450:0.011738:0.013143:0.013123:0.006523:0.012508:0.005792:0.010391:0.005713:0.012508:0.012950:0.013143:0.005673:0.013181:0.003848:0.011738:0.012950:0.010391:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005330
childhood  cancers.  These  cancers  in-:@0.524242:0.390442:0.915147:0.390442:0.915147:0.374686:0.524242:0.374686:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330:0.010897:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.005330:0.010891:0.008197:0.011738:0.012508:0.007466:0.012508:0.005330:0.010895:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.007466:0.005330:0.010897:0.003848:0.011738:0.006388
clude bone tumours, sarcomas and other :@0.524242:0.406913:0.920485:0.406913:0.920485:0.391157:0.524242:0.391157:0.012450:0.003848:0.011699:0.013181:0.012508:0.006177:0.013123:0.012604:0.011738:0.012508:0.006177:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.006177:0.007466:0.013143:0.005661:0.012450:0.012604:0.018049:0.013143:0.007466:0.006177:0.013143:0.011738:0.013181:0.006177:0.012604:0.006523:0.011738:0.012508:0.005792:0.005330
embryonal  tumours.  A  high  index  of  sus-:@0.524242:0.423383:0.915142:0.423383:0.915142:0.407627:0.524242:0.407627:0.012508:0.018049:0.013123:0.005792:0.010314:0.012604:0.011738:0.013143:0.003848:0.005330:0.003662:0.006523:0.011699:0.018049:0.012604:0.011699:0.005792:0.007466:0.005330:0.005330:0.003648:0.014239:0.005330:0.003658:0.011738:0.003848:0.012950:0.011738:0.005330:0.003660:0.003848:0.011738:0.013181:0.012508:0.009236:0.005330:0.003660:0.012604:0.006042:0.005330:0.003658:0.007466:0.011699:0.007466:0.006388
picion is needed  to  ensure  early referral :@0.524242:0.439853:0.920510:0.439853:0.920510:0.424097:0.524242:0.424097:0.013123:0.003848:0.012450:0.003848:0.012604:0.011738:0.009121:0.003848:0.007466:0.009121:0.011738:0.012508:0.012508:0.013181:0.012508:0.013181:0.005330:0.003779:0.006523:0.012604:0.005330:0.003773:0.012508:0.011738:0.007466:0.011699:0.005711:0.012508:0.005330:0.003777:0.012508:0.013143:0.005792:0.003848:0.010314:0.009121:0.005713:0.012508:0.006042:0.012508:0.005792:0.005792:0.013143:0.003848:0.005330
for specialised  investigations in a tertiary :@0.524242:0.456324:0.920479:0.456324:0.920479:0.440568:0.524242:0.440568:0.006042:0.012604:0.005792:0.009005:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.012508:0.013181:0.005330:0.003693:0.003848:0.011738:0.010660:0.012508:0.007466:0.006523:0.003848:0.012950:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.009005:0.003848:0.011738:0.009005:0.013143:0.009005:0.006523:0.012508:0.005792:0.006523:0.003848:0.013143:0.005792:0.010314:0.005330
centre to diagnose a potential childhood :@0.524242:0.472794:0.920497:0.472794:0.920497:0.457038:0.524242:0.457038:0.012450:0.012508:0.011738:0.006523:0.005705:0.012508:0.006144:0.006523:0.012604:0.006142:0.013181:0.003848:0.013143:0.012950:0.011738:0.012604:0.007466:0.012508:0.006144:0.013143:0.006148:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.006158:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330
cancer.  Both  the  South  African Children :@0.524242:0.489264:0.920503:0.489264:0.920503:0.473508:0.524242:0.473508:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330:0.005330:0.004397:0.011045:0.012604:0.006523:0.011738:0.005330:0.004395:0.006523:0.011738:0.012508:0.005330:0.004397:0.009583:0.012604:0.011699:0.006523:0.011738:0.005330:0.004389:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.011738:0.009737:0.015644:0.011738:0.003848:0.003848:0.013181:0.005719:0.012508:0.011738:0.005330
Cancer Study Group members (SACCSG) :@0.524242:0.505735:0.920478:0.505735:0.920478:0.489979:0.524242:0.489979:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.006312:0.009583:0.006523:0.011699:0.013181:0.010314:0.006312:0.016779:0.005711:0.012604:0.011699:0.013123:0.006312:0.018049:0.012508:0.018049:0.013123:0.012508:0.005792:0.007466:0.006312:0.007100:0.009583:0.014239:0.015644:0.015644:0.009583:0.016779:0.007100:0.005330
and the Childhood Cancer Foundation of :@0.524242:0.522205:0.920504:0.522205:0.920504:0.506449:0.524242:0.506449:0.013143:0.011738:0.013181:0.005484:0.006523:0.011738:0.012508:0.005484:0.015644:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005473:0.015644:0.013143:0.011738:0.012450:0.012508:0.005792:0.005473:0.009333:0.012604:0.011699:0.011738:0.013181:0.013143:0.006523:0.003848:0.012604:0.011738:0.005473:0.012604:0.006042:0.005330
South Africa (CHOC) can provide advice :@0.524242:0.538675:0.920489:0.538675:0.920489:0.522919:0.524242:0.522919:0.009583:0.012604:0.011699:0.006523:0.011738:0.006616:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.006625:0.007100:0.015644:0.013143:0.016722:0.015644:0.007100:0.006639:0.012450:0.013143:0.011738:0.006625:0.013123:0.005715:0.012604:0.010660:0.003848:0.013181:0.012508:0.006639:0.013143:0.013181:0.010660:0.003848:0.012450:0.012508:0.005330
to any health-care worker and/or parent if :@0.524242:0.555145:0.920489:0.555145:0.920489:0.539390:0.524242:0.539390:0.006523:0.012604:0.004505:0.013143:0.011738:0.010314:0.004522:0.011738:0.012508:0.013143:0.003848:0.006523:0.011738:0.006388:0.012450:0.013143:0.005715:0.012508:0.004508:0.015990:0.012604:0.005792:0.009660:0.012508:0.005792:0.004499:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.004503:0.013123:0.013143:0.005719:0.012508:0.011738:0.006523:0.004503:0.003848:0.006042:0.005330
concerned about potential warning signs :@0.524242:0.571616:0.920493:0.571616:0.920493:0.555860:0.524242:0.555860:0.012450:0.012604:0.011738:0.012450:0.012508:0.006183:0.011738:0.012508:0.013181:0.006388:0.013143:0.013123:0.012604:0.011699:0.006523:0.006377:0.013123:0.012604:0.006523:0.012508:0.011738:0.006523:0.003848:0.013143:0.003848:0.006388:0.015990:0.013143:0.006194:0.011738:0.003848:0.011738:0.012950:0.006388:0.007466:0.003848:0.012950:0.011738:0.007466:0.005330
of childhood cancer.:@0.524242:0.588086:0.720718:0.588086:0.720718:0.572330:0.524242:0.572330:0.012604:0.006042:0.005330:0.012450:0.011738:0.003848:0.003848:0.013181:0.011738:0.012604:0.012604:0.013181:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.004360:0.005330
18,19:@0.720716:0.582485:0.748683:0.582485:0.748683:0.573300:0.720716:0.573300:0.006215:0.006215:0.003107:0.006215:0.006215
REFERENCES:@0.524242:0.618107:0.635078:0.618107:0.635078:0.602074:0.524242:0.602074:0.011161:0.010006:0.009236:0.010006:0.011161:0.010006:0.014239:0.015009:0.010006:0.010006
1. :@0.524242:0.635138:0.543193:0.635138:0.543193:0.621132:0.524242:0.621132:0.009476:0.004738:0.004738
  Scheurer  ME,  Lupo  PJ,  Bondy  ML.  Epide-:@0.560589:0.635138:0.915141:0.635138:0.915141:0.621132:0.560589:0.621132:0.004738:-0.004738:0.008518:0.011067:0.010434:0.011118:0.010399:0.005073:0.011118:0.005148:0.004738:0.004312:0.015719:0.009168:0.004738:0.004738:0.004315:0.007902:0.010399:0.011665:0.011203:0.004738:0.004314:0.010126:0.008244:0.004738:0.004738:0.004310:0.009818:0.011203:0.010434:0.011716:0.009168:0.004738:0.004319:0.015719:0.007902:0.004738:0.004738:0.004312:0.009168:0.011665:0.003421:0.011716:0.011118:0.005679
miology of childhood cancer. In: Pizzo PA, :@0.560589:0.649554:0.919902:0.649554:0.919902:0.635549:0.560589:0.635549:0.016044:0.003421:0.011203:0.003421:0.011203:0.011511:0.009168:0.006483:0.011203:0.005371:0.006474:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.006474:0.011067:0.011682:0.010434:0.011067:0.011118:0.003890:0.004738:0.006474:0.003866:0.010434:0.004738:0.006474:0.010126:0.003421:0.007269:0.007269:0.011203:0.006467:0.008853:0.012657:0.004738:0.004738
Poplack  DG, editors. :@0.560589:0.663971:0.741510:0.663971:0.741510:0.649966:0.560589:0.649966:0.010126:0.011203:0.011665:0.003421:0.011682:0.011067:0.008586:0.004738:0.003395:0.012726:0.014915:0.004738:0.008142:0.011118:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738
Principles and  Prac-:@0.744888:0.663971:0.915152:0.663971:0.915152:0.649966:0.744888:0.649966:0.010126:0.005148:0.003421:0.010434:0.011067:0.003421:0.011665:0.003421:0.011118:0.006636:0.008142:0.011682:0.010434:0.011716:0.004738:0.003394:0.010126:0.005148:0.011682:0.011067:0.005679
tice  of  Pediatric  Oncology:@0.560589:0.678388:0.788655:0.678388:0.788655:0.664383:0.560589:0.664383:0.005798:0.003421:0.011067:0.011118:0.004738:0.003169:0.011203:0.005371:0.004738:0.003166:0.010126:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.004738:0.003171:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
,  7th  ed.  Phila-:@0.788655:0.678388:0.915153:0.678388:0.915153:0.664383:0.788655:0.664383:0.004738:0.004738:0.003168:0.009476:0.005798:0.010434:0.004738:0.003169:0.011118:0.011716:0.004738:0.004738:0.003168:0.010126:0.010434:0.003421:0.003421:0.011682:0.005679
delphia (PA): Wolters Kluwer; 2016:2-9.:@0.560589:0.691923:0.871985:0.691923:0.871985:0.677918:0.560589:0.677918:0.011716:0.011118:0.003421:0.011665:0.010434:0.003421:0.011682:0.004738:0.006312:0.008860:0.012657:0.006312:0.004738:0.004738:0.015628:0.011203:0.003421:0.005798:0.011118:0.005148:0.006636:0.004738:0.010109:0.003421:0.010399:0.014214:0.011118:0.005148:0.004738:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.005679:0.009476:0.004738
2. :@0.524242:0.705458:0.543193:0.705458:0.543193:0.691453:0.524242:0.691453:0.009476:0.004738:0.004738
  Steliarova-Foucher  E,  Colombet  M,  Ries :@0.560589:0.705458:0.919888:0.705458:0.919888:0.691453:0.560589:0.691453:0.004738:-0.004738:0.008518:0.005798:0.011118:0.003421:0.003421:0.011682:0.005083:0.011203:0.009476:0.011682:0.005679:0.008296:0.011203:0.010399:0.011067:0.010434:0.011118:0.005148:0.004738:0.007637:0.009168:0.004738:0.004738:0.007651:0.013906:0.011203:0.003421:0.011203:0.016044:0.011665:0.011118:0.005798:0.004738:0.007649:0.015719:0.004738:0.004738:0.007647:0.010382:0.003421:0.011118:0.006636:0.004738
LAG, :@0.560589:0.718993:0.605539:0.718993:0.605539:0.704988:0.560589:0.704988:0.007902:0.012657:0.014915:0.004738:0.004738
et al:@0.615288:0.718993:0.661795:0.718993:0.661795:0.704988:0.615288:0.704988:0.011118:0.005798:0.014487:0.011682:0.003421
. International incidence of :@0.661795:0.718993:0.919895:0.718993:0.919895:0.704988:0.661795:0.704988:0.004738:0.014487:0.003866:0.010434:0.005798:0.011118:0.005502:0.010434:0.011682:0.005798:0.003421:0.011203:0.010434:0.011682:0.003421:0.014487:0.003421:0.010434:0.011067:0.003421:0.011716:0.011118:0.010434:0.011067:0.011118:0.014487:0.011203:0.005371:0.004738
childhood  cancer,  2001-10:  a  population :@0.560589:0.732528:0.919888:0.732528:0.919888:0.718522:0.560589:0.718522:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.004738:0.004416:0.011067:0.011682:0.010434:0.011067:0.011118:0.003347:0.004738:0.004738:0.004418:0.009476:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.004738:0.004738:0.004440:0.011682:0.004738:0.004421:0.011665:0.011203:0.011665:0.010399:0.003421:0.011682:0.005798:0.003421:0.011203:0.010434:0.004738
based registry study. :@0.560589:0.746063:0.749383:0.746063:0.749383:0.732057:0.560589:0.732057:0.011665:0.011682:0.006636:0.011118:0.011716:0.012452:0.005077:0.011118:0.011511:0.003421:0.006636:0.005798:0.005148:0.009168:0.012452:0.006636:0.005798:0.010399:0.011716:0.009168:0.004738:0.004738
Lancet Oncology.:@0.757097:0.746063:0.915159:0.746063:0.915159:0.732057:0.757097:0.732057:0.007902:0.011682:0.010434:0.011067:0.011118:0.005798:0.012452:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168:0.004738
 :@0.915145:0.746063:0.919883:0.746063:0.919883:0.732057:0.915145:0.732057:0.004738
2017;18:719-731.:@0.560589:0.759598:0.694191:0.759598:0.694191:0.745592:0.560589:0.745592:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738
3. :@0.524242:0.773132:0.543193:0.773132:0.543193:0.759127:0.524242:0.759127:0.009476:0.004738:0.004738
  Rabin KR, Gramatges MM, Margolin JF, :@0.560589:0.773132:0.895913:0.773132:0.895913:0.759127:0.560589:0.759127:0.004738:-0.004738:0.010382:0.011682:0.011665:0.003421:0.010434:0.007064:0.010109:0.010382:0.004738:0.007064:0.014915:0.005148:0.011682:0.016044:0.011682:0.005798:0.011511:0.011118:0.006636:0.007064:0.015719:0.015719:0.004738:0.007064:0.015719:0.011682:0.005162:0.011511:0.011203:0.003421:0.003421:0.010434:0.007064:0.008244:0.006205:0.004738:0.004738
et :@0.898239:0.773132:0.919893:0.773132:0.919893:0.759127:0.898239:0.759127:0.011118:0.005798:0.004738
al:@0.560589:0.786667:0.575692:0.786667:0.575692:0.772662:0.560589:0.772662:0.011682:0.003421
. Acute lymphoblastic leukemia. In: Pizzo :@0.575692:0.786667:0.919912:0.786667:0.919912:0.772662:0.575692:0.772662:0.004738:0.005839:0.012657:0.011067:0.010399:0.005798:0.011118:0.005850:0.003421:0.009168:0.016044:0.011665:0.010434:0.011203:0.011665:0.003421:0.011682:0.006636:0.005798:0.003421:0.011067:0.005850:0.003421:0.011118:0.010399:0.008586:0.011118:0.016044:0.003421:0.011682:0.004738:0.005850:0.003866:0.010434:0.004738:0.005838:0.010126:0.003421:0.007269:0.007269:0.011203:0.004738
PA,  Poplack DG,  editors. :@0.560589:0.800202:0.786354:0.800202:0.786354:0.786197:0.560589:0.786197:0.008853:0.012657:0.004738:0.004738:0.006879:0.010126:0.011203:0.011665:0.003421:0.011682:0.011067:0.008586:0.011631:0.012726:0.014915:0.004738:0.004738:0.006885:0.011118:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738
Principles and :@0.793225:0.800202:0.919883:0.800202:0.919883:0.786197:0.793225:0.786197:0.010126:0.005148:0.003421:0.010434:0.011067:0.003421:0.011665:0.003421:0.011118:0.006636:0.011631:0.011682:0.010434:0.011716:0.004738
Practice  of  Pediatric Oncology:@0.560589:0.813290:0.835471:0.813290:0.835471:0.799285:0.560589:0.799285:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.004738:0.006096:0.011203:0.005371:0.004738:0.006098:0.010126:0.011118:0.011716:0.003421:0.011682:0.005798:0.005148:0.003421:0.011067:0.010844:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
, 7th ed. :@0.835471:0.813290:0.919915:0.813290:0.919915:0.799285:0.835471:0.799285:0.004738:0.010844:0.009476:0.005798:0.010434:0.010844:0.011118:0.011716:0.004738:0.004738
Philadelphia (PA): Wolters Kluwer; 2016:463.:@0.560589:0.826531:0.914854:0.826531:0.914854:0.812526:0.560589:0.812526:0.010126:0.010434:0.003421:0.003421:0.011682:0.011716:0.011118:0.003421:0.011665:0.010434:0.003421:0.011682:0.004738:0.006312:0.008863:0.012657:0.006312:0.004738:0.004738:0.015627:0.011203:0.003421:0.005798:0.011118:0.005148:0.006636:0.004738:0.010109:0.003421:0.010399:0.014214:0.011118:0.005148:0.004738:0.004738:0.009462:0.009476:0.009476:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738
4. :@0.524242:0.839772:0.543193:0.839772:0.543193:0.825767:0.524242:0.825767:0.009476:0.004738:0.004738
  Freedman JL, Rheingold SR, Fisher MJ. On-:@0.560589:0.839772:0.915174:0.839772:0.915174:0.825767:0.560589:0.825767:0.004738:-0.004738:0.008296:0.005075:0.011118:0.011118:0.011716:0.016044:0.011682:0.010434:0.006038:0.008244:0.007902:0.004738:0.006029:0.010382:0.010434:0.011118:0.003421:0.010434:0.011511:0.011203:0.003421:0.011716:0.006029:0.008518:0.010382:0.004738:0.006038:0.008296:0.003421:0.006636:0.010434:0.011118:0.005148:0.006038:0.015719:0.008244:0.004738:0.006038:0.014864:0.010434:0.005679
cologic emergencies. In: Pizzo PA, Poplack :@0.560589:0.853013:0.919903:0.853013:0.919903:0.839008:0.560589:0.839008:0.011067:0.011203:0.003421:0.011203:0.011511:0.003421:0.011067:0.005183:0.011118:0.016044:0.011118:0.005148:0.011511:0.011118:0.010434:0.011067:0.003421:0.011118:0.006636:0.004738:0.005183:0.003866:0.010434:0.004738:0.005183:0.010126:0.003421:0.007269:0.007269:0.011203:0.005169:0.008853:0.012657:0.004738:0.005172:0.010126:0.011203:0.011665:0.003421:0.011682:0.011067:0.008586:0.004738
DG, editors. :@0.560589:0.866254:0.661504:0.866254:0.661504:0.852249:0.560589:0.852249:0.012726:0.014915:0.004738:0.004020:0.011118:0.011716:0.003421:0.005798:0.011203:0.005148:0.006636:0.004738:0.004738
Principles and Practice of Pedi-:@0.660769:0.866254:0.915169:0.866254:0.915169:0.852249:0.660769:0.852249:0.010126:0.005148:0.003421:0.010434:0.011067:0.003421:0.011665:0.003421:0.011118:0.006636:0.004020:0.011682:0.010434:0.011716:0.004020:0.010126:0.005148:0.011682:0.011067:0.005798:0.003421:0.011067:0.011118:0.004004:0.011203:0.005371:0.004008:0.010126:0.011118:0.011716:0.003421:0.005679
atric Oncology:@0.560589:0.879495:0.687606:0.879495:0.687606:0.865490:0.560589:0.865490:0.011682:0.005798:0.005148:0.003421:0.011067:0.007030:0.014864:0.010434:0.011067:0.011203:0.003421:0.011203:0.011511:0.009168
, 7th ed. Philadelphia (PA): :@0.687606:0.879495:0.919895:0.879495:0.919895:0.865490:0.687606:0.865490:0.004738:0.007030:0.009476:0.005798:0.010434:0.007030:0.011118:0.011716:0.004738:0.007030:0.010126:0.010434:0.003421:0.003421:0.011682:0.011716:0.011118:0.003421:0.011665:0.010434:0.003421:0.011682:0.007030:0.006312:0.008855:0.012657:0.006312:0.004738:0.004738
Wolters Kluwer; 2016:967.:@0.560589:0.893618:0.763977:0.893618:0.763977:0.879613:0.560589:0.879613:0.015635:0.011203:0.003421:0.005798:0.011118:0.005148:0.006636:0.004738:0.010109:0.003421:0.010399:0.014214:0.011118:0.005148:0.004738:0.004738:0.009476:0.009476:0.009474:0.009476:0.004738:0.009476:0.009476:0.009476:0.004738
5. :@0.524242:0.907741:0.543193:0.907741:0.543193:0.893735:0.524242:0.893735:0.009476:0.004738:0.004738
  Greaves M. Infection,  immune responses :@0.560589:0.907741:0.919886:0.907741:0.919886:0.893735:0.560589:0.893735:0.004738:-0.004738:0.014915:0.005078:0.011118:0.011682:0.009476:0.011118:0.006636:0.009664:0.015719:0.004738:0.009664:0.003866:0.010434:0.005371:0.011118:0.011067:0.005798:0.003421:0.011203:0.010434:0.004738:0.004738:0.004916:0.003421:0.016044:0.016044:0.010399:0.010434:0.011118:0.009664:0.005078:0.011118:0.006636:0.011665:0.011203:0.010434:0.006636:0.011118:0.006636:0.004738
and the aetiology of childhood leukaemia. :@0.560589:0.921864:0.919900:0.921864:0.919900:0.907858:0.560589:0.907858:0.011682:0.010434:0.011716:0.004293:0.005798:0.010434:0.011118:0.004293:0.011682:0.011118:0.005798:0.003421:0.011203:0.003421:0.011203:0.011511:0.009168:0.004293:0.011203:0.005371:0.004293:0.011067:0.010434:0.003421:0.003421:0.011716:0.010434:0.011203:0.011203:0.011716:0.004293:0.003421:0.011118:0.010399:0.008586:0.011682:0.011118:0.016044:0.003421:0.011682:0.004738:0.004738
Nat Rev Cancer.:@0.560589:0.935986:0.699271:0.935986:0.699271:0.921981:0.560589:0.921981:0.012657:0.011682:0.005798:0.004738:0.010382:0.011118:0.009476:0.004738:0.013906:0.011682:0.010434:0.011067:0.011118:0.005148:0.004738
 2006;6:193-203.:@0.699254:0.935986:0.828118:0.935986:0.828118:0.921981:0.699254:0.921981:0.004738:0.009476:0.009476:0.009476:0.009476:0.004738:0.009476:0.004738:0.009476:0.009476:0.009476:0.005679:0.009476:0.009476:0.009476:0.004738